Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.343 USD | -2.01% | +9.06% | +104.17% |
Apr. 02 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 | |
Apr. 01 | BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 19.05M | Sales 2025 * | 25.76M | Capitalization | 102M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | - | EV / Sales 2024 * | 5.33 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.94 x |
P/E ratio 2024 * |
-34.3
x | P/E ratio 2025 * |
-
| Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.75% |
Latest transcript on BioLargo, Inc.
1 day | -2.01% | ||
1 week | +9.06% | ||
Current month | -3.35% | ||
1 month | -0.44% | ||
3 months | +61.11% | ||
6 months | +102.24% | ||
Current year | +104.17% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Director of Finance/CFO | 68 | 08-01-31 | |
Chief Operating Officer | 55 | 02-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.343 | -2.01% | 89,426 |
24-04-24 | 0.35 | -0.43% | 246,564 |
24-04-23 | 0.3515 | +4.93% | 122,885 |
24-04-22 | 0.335 | -1.36% | 179,674 |
24-04-19 | 0.3396 | +7.99% | 175,745 |
Delayed Quote OTC Markets, April 25, 2024 at 03:55 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+104.17% | 104M | |
+4.26% | 104B | |
-5.63% | 63.11B | |
+40.95% | 39.72B | |
+10.00% | 36.58B | |
+4.84% | 32.8B | |
+6.01% | 19.26B | |
+11.51% | 16.66B | |
+18.30% | 15.23B | |
+5.60% | 14.74B |
- Stock Market
- Equities
- BLGO Stock